Database for patients with bone metastases
Official title: Banca Dati Nazionale Metastasi Ossee
Run by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · NCT06367491 · Data updated 2026-11-12
This study is collecting information from adults with bone metastases to help improve understanding and treatment of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Academic / other |
| Locations | 30 sites (Imola, Bologna and 29 other locations) |
| Status | Recruiting |
| Started | October 8, 2013 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | April 16, 2024 |
| Trial ID | NCT06367491 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a confirmed diagnosis of bone metastasis from a solid tumor.
✕Probably not a fit
Patients without a diagnosis of bone metastasis or those under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data from patients diagnosed with bone metastases across multiple Italian centers. Utilizing a custom online software, the study aims to gather comprehensive information on these patients to better understand the condition and improve future treatment strategies. Participants must be 18 years or older and provide informed consent to be included in the database. The study does not involve any specific interventions beyond registration.
Why it matters
Potential benefit: If successful, this study could enhance understanding of bone metastases and inform better treatment approaches for affected patients.
How similar studies have gone: While this approach is observational and data-driven, similar studies have shown success in improving patient outcomes through better data collection and analysis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Radiological and/or histological diagnosis of bone metastasis from histologically established solid tumor * Males or females aged \>= 18 years * Informed consent Exclusion Criteria: * Not applicable
Where it's running
-
A.U.S.L. Imola
Imola, Bologna, Italy Recruiting -
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Meldola, Fc, Italy Recruiting -
Osp. S. Vincenzo - ASP Messina
Taormina, Messina, Italy Recruiting -
Osp. Ramazzini di Carpi - AUSL Modena
Carpi, Modena, Italy Recruiting -
P.O. "S. Maria delle Grazie"
Pozzuoli, Napoli, Italy Recruiting -
Osp. degli Infermi
Faenza, Ravenna, Italy Recruiting
Show 24 more locations
-
Ospedale Umberto I
Lugo, Ravenna, Italy Recruiting -
Istituto Neurotraumatologico Italiano (INI)
Grottaferrata, Roma, Italy Recruiting -
A.O.U. Ospedali Riuniti
Ancona, Italy Recruiting -
Centro di Riferimento Oncologico - IRCCS CRO
Aviano, Italy Recruiting -
A.O.U.C. Policlinico di Bari Osp."Giovanni XXIII"
Bari, Italy Recruiting -
A.O. "S. Pio"
Benevento, Italy Recruiting -
IRCCS Ist. Ortopedico Rizzoli
Bologna, Italy Recruiting -
ASST Spedali Civili di Brescia
Brescia, Italy Recruiting -
A.O. S. Croce e Carle
Cuneo, Italy Recruiting -
A.O.U. "Arcispedale S. Anna" - AUSL Ferrara
Ferrara, Italy Recruiting -
Ospedale Civile di Legnano - ASST Ovest Milanese
Legnano, Italy Recruiting -
Fond. IRCCS Istituto Nazionale dei Tumori - INT
Milan, Italy Recruiting -
A.O.R.N. "A. Cardarelli"
Naples, Italy Recruiting -
Istituto Oncologico Veneto
Padova, Italy Recruiting -
Fond. IRCCS Policlinico San Matteo
Pavia, Italy Recruiting -
Osp. Guglielmo da Saliceto
Piacenza, Italy Recruiting -
Osp. S. Maria delle Croci
Ravenna, Italy Recruiting -
IRCCS Arcispedale S. Maria Nuova - A.O. Reggio Emilia
Reggio Emilia, Italy Recruiting -
Ospedale degli Infermi
Rimini, Italy Recruiting -
IRCCS Fond. Policlinico "A. Gemelli" - U.O.C. Oncologia Medica
Roma, Italy Recruiting -
IRCCS Fond. Policlinico "A. Gemelli" - U.O.S. Senologia Medica / U.O.C. Ginecologia oncologica
Roma, Italy Recruiting -
Ospedale di Treviglio - Caravaggio ASST Bergamo Ovest
Treviglio, Italy Recruiting -
A.O.U.I. Verona
Verona, Italy Recruiting -
Osp. "Sacro Cuore di Gesù"
Gallipoli, Lecce, Italy Not yet recruiting
Study contacts
- Study coordinator: Nicoletta Ranallo, MD
- Email: nicoletta.ranallo@irst.emr.it
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prophylactic Radiotherapy to Prevent Bone Complications in Metastatic Cancers
This study tests whether giving early radiotherapy to high-risk bone metastases, in addition to standard care, can reduce bone-related problems in adults with metastatic solid cancers.
-
Focused high-dose SBRT for spinal tumors
This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.
-
Registry for people with symptomatic bone metastases
This registry collects health information from adults with symptomatic bone metastases who need treatment for painful or unstable bone lesions to learn more about outcomes and care.
-
One-visit, simulation-free single-dose radiation for painful bone metastases
This trial tests whether adults with one or two painful bone metastases can get pain-relieving radiation in a single visit using a simulation-free planning approach.
-
Dual Energy CT to Delineate Tumors and Organs at Risk in Radiotherapy
This study tests whether dual-energy CT can delineate tumors and nearby critical tissues as well as MRI for patients needing radiotherapy.
-
Early radiotherapy versus observation for high‑risk painless or minimally painful bone metastases
This will test whether giving preventive radiotherapy to people with high‑risk but painless or minimally painful bone metastases can reduce future bone complications, hospital stays, and symptoms compared with observation and usual treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.